{"DataElement":{"publicId":"2963655","version":"1","preferredName":"Neoplasm Assessment Method Type","preferredDefinition":"A description of the neoplasm assessment method.","longName":"NM_AT_MD_TE","context":"NHLBI","contextVersion":"1","DataElementConcept":{"publicId":"2963648","version":"1","preferredName":"Neoplasm Assessment Method","preferredDefinition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation.  Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia.  Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias._The final result of a determination of the value, significance, or extent of._A means, manner of procedure, or systematic course of actions that have to be performed in order to accomplish a particular goal.","longName":"NPSM_ASMT_MTD","context":"NCI Standards","contextVersion":"1","ObjectClass":{"publicId":"2404687","version":"1","preferredName":"Neoplasm","preferredDefinition":"(NEE-o-PLAY-zha) Abnormal and uncontrolled cell growth.","longName":"C3262","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0094ACAF-11BC-1BCA-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-09-12","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-09-12","modifiedBy":"ONEDATA","dateModified":"2005-09-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2963646","version":"1","preferredName":"Assessment Method","preferredDefinition":"Having determined the value, significance, or extent of.:A means, manner of procedure, or systematic course of actions that have to be performed in order to accomplish a particular goal.","longName":"C25217:C71460","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Assessment","conceptCode":"C25217","definition":"The final result of a determination of the value, significance, or extent of.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Method","conceptCode":"C71460","definition":"A means, manner of procedure, or systematic course of actions that have to be performed in order to accomplish a particular goal.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"795188DE-69FF-0188-E040-BB89AD4374D4","latestVersionIndicator":"Yes","beginDate":"2009-11-26","endDate":null,"createdBy":"MOROZOFA","dateCreated":"2009-11-26","modifiedBy":"ONEDATA","dateModified":"2009-11-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"795188DE-6A10-0188-E040-BB89AD4374D4","latestVersionIndicator":"Yes","beginDate":"2009-11-26","endDate":null,"createdBy":"MOROZOFA","dateCreated":"2009-11-26","modifiedBy":"TAYLORT","dateModified":"2018-10-22","changeDescription":"10-22-18 Registration status changed to Qualified/TMT.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2963650","version":"1","preferredName":"Neoplasm Assessment Type","preferredDefinition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation.  Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia.  Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias._The final result of a determination of the value, significance, or extent of._Type; a subdivision of a particular kind of thing.","longName":"NM_ASMT_TPE","context":"NHLBI","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"100","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"plain film / x-ray without contrast","valueDescription":"X-Ray Without Contrast","ValueMeaning":{"publicId":"2963651","version":"1","preferredName":"X-Ray Without Contrast","longName":"2963651","preferredDefinition":"A type of high-energy radiation.  In low doses, x-rays are used to diagnose diseases by making pictures of the inside of the body.  In high doses, x-rays are used to treat cancer.: Used to indicate the absence or lack of something or someone. (from Merriam-Webster OnLine): The degree of difference between the lightest and darkest areas of an image or object.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"X-Ray","conceptCode":"C17262","definition":"Ionizing electromagnetic radiation having a wavelength that is shorter than ultraviolet radiation and longer than gamma radiation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Without","conceptCode":"C25718","definition":"Used to indicate the absence or lack of something or someone.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Contrast","conceptCode":"C70754","definition":"The degree of difference between the lightest and darkest areas of an image or object.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7952173B-DF3D-DA26-E040-BB89AD432DA2","latestVersionIndicator":"Yes","beginDate":"2009-11-26","endDate":null,"createdBy":"MOROZOFA","dateCreated":"2009-11-26","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7952173B-DF56-DA26-E040-BB89AD432DA2","beginDate":"2009-11-26","endDate":null,"createdBy":"MOROZOFA","dateCreated":"2009-11-26","modifiedBy":"ONEDATA","dateModified":"2009-11-26","deletedIndicator":"No"},{"value":"plain film / x-ray with contrast","valueDescription":"X-Ray With Contrast","ValueMeaning":{"publicId":"2963652","version":"1","preferredName":"X-Ray With Contrast","longName":"2963652","preferredDefinition":"A type of high-energy radiation.  In low doses, x-rays are used to diagnose diseases by making pictures of the inside of the body.  In high doses, x-rays are used to treat cancer.: Used to indicate the presence of something or someone.: The degree of difference between the lightest and darkest areas of an image or object.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"X-Ray","conceptCode":"C17262","definition":"Ionizing electromagnetic radiation having a wavelength that is shorter than ultraviolet radiation and longer than gamma radiation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"With","conceptCode":"C62355","definition":"Used to indicate the presence of something or someone.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Contrast","conceptCode":"C70754","definition":"The degree of difference between the lightest and darkest areas of an image or object.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7952173B-DF64-DA26-E040-BB89AD432DA2","latestVersionIndicator":"Yes","beginDate":"2009-11-26","endDate":null,"createdBy":"MOROZOFA","dateCreated":"2009-11-26","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7952173B-DF7D-DA26-E040-BB89AD432DA2","beginDate":"2009-11-26","endDate":null,"createdBy":"MOROZOFA","dateCreated":"2009-11-26","modifiedBy":"ONEDATA","dateModified":"2009-11-26","deletedIndicator":"No"},{"value":"apparent by visualization","valueDescription":"Visual Assessment","ValueMeaning":{"publicId":"2963653","version":"1","preferredName":"Visual Assessment","longName":"2963653","preferredDefinition":"Visual; relating to or using sight; able to be seen.: Having determined the value, significance, or extent of.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Visual","conceptCode":"C38059","definition":"Relating to or using sight; able to be seen.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Assessment","conceptCode":"C25217","definition":"The final result of a determination of the value, significance, or extent of.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7952173B-DF8A-DA26-E040-BB89AD432DA2","latestVersionIndicator":"Yes","beginDate":"2009-11-26","endDate":null,"createdBy":"MOROZOFA","dateCreated":"2009-11-26","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7952173B-DFA3-DA26-E040-BB89AD432DA2","beginDate":"2009-11-26","endDate":null,"createdBy":"MOROZOFA","dateCreated":"2009-11-26","modifiedBy":"ONEDATA","dateModified":"2009-11-26","deletedIndicator":"No"},{"value":"apparent by palpation","valueDescription":"Palpation","ValueMeaning":{"publicId":"2832987","version":"1","preferredName":"Palpation","longName":"2832987","preferredDefinition":"Examination by pressing on the surface of the body to feel the organs or tissues underneath.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Palpation","conceptCode":"C16950","definition":"A method of feeling with the hands during a physical examination. The health care provider touches and feels the patient's body to examine the size, consistency, texture, location and tenderness of an organ or body part.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6218E430-FD1F-BB6A-E040-BB89AD431295","latestVersionIndicator":"Yes","beginDate":"2009-02-04","endDate":null,"createdBy":"LEEB","dateCreated":"2009-02-04","modifiedBy":"ONEDATA","dateModified":"2009-02-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7952173B-DFB7-DA26-E040-BB89AD432DA2","beginDate":"2009-11-26","endDate":null,"createdBy":"MOROZOFA","dateCreated":"2009-11-26","modifiedBy":"ONEDATA","dateModified":"2009-11-26","deletedIndicator":"No"},{"value":"other method","valueDescription":"Other","ValueMeaning":{"publicId":"2946060","version":"1","preferredName":"Other","longName":"2946060","preferredDefinition":"Different than the one(s) previously specified or mentioned.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"746A8063-D650-3C9D-E040-BB89AD437A9B","latestVersionIndicator":"Yes","beginDate":"2009-09-25","endDate":null,"createdBy":"AHMEDS","dateCreated":"2009-09-25","modifiedBy":"GDEEN","dateModified":"2024-01-19","changeDescription":null,"administrativeNotes":"1/25/23 added alt name for ticket number CADSR0001948 for CCTG cjl.","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7952173B-DFCB-DA26-E040-BB89AD432DA2","beginDate":"2009-11-26","endDate":null,"createdBy":"MOROZOFA","dateCreated":"2009-11-26","modifiedBy":"ONEDATA","dateModified":"2009-11-26","deletedIndicator":"No"},{"value":"MRI scan","valueDescription":"MRI","ValueMeaning":{"publicId":"2571738","version":"1","preferredName":"MRI","longName":"2571738","preferredDefinition":"Imaging that uses radiofrequency waves and a strong magnetic field rather than x-rays to provide amazingly clear and detailed pictures of internal organs and tissues. The technique is valuable for the diagnosis of many pathologic conditions, including cancer, heart and vascular disease, stroke, and joint and musculoskeletal disorders.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Magnetic Resonance Imaging","conceptCode":"C16809","definition":"Imaging that uses radiofrequency waves and a strong magnetic field rather than x-rays to provide detailed pictures of internal organs and tissues. The technique is valuable for the diagnosis of many pathologic conditions, including cancer, heart and vascular disease, stroke, and joint and musculoskeletal disorders.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-E547-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-08-19","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-08-19","modifiedBy":"TAYLORT","dateModified":"2016-04-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7952173B-DFDF-DA26-E040-BB89AD432DA2","beginDate":"2009-11-26","endDate":null,"createdBy":"MOROZOFA","dateCreated":"2009-11-26","modifiedBy":"ONEDATA","dateModified":"2009-11-26","deletedIndicator":"No"},{"value":"CT Scan","valueDescription":"Computed Tomography","ValueMeaning":{"publicId":"2797567","version":"1","preferredName":"Computed Tomography","longName":"2797567","preferredDefinition":"A method of examining body organs by scanning them with X rays and using a computer to construct a series of cross-sectional scans along a single axis. ","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Computed Tomography","conceptCode":"C17204","definition":"A method of examining structures within the body by scanning them with X rays and using a computer to construct a series of cross-sectional scans along a single axis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5AF0AF2B-2DAF-37BC-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"CHILLIJ","dateCreated":"2008-11-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7952173B-DFE9-DA26-E040-BB89AD432DA2","beginDate":"2009-11-26","endDate":null,"createdBy":"MOROZOFA","dateCreated":"2009-11-26","modifiedBy":"ONEDATA","dateModified":"2009-11-26","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2963649","version":"1","preferredName":"Neoplasm Assessment Type","preferredDefinition":"(NEE-o-PLAY-zha) Abnormal and uncontrolled cell growth.:Having determined the value, significance, or extent of.:Type; a subdivision of a particular kind of thing.","longName":"C3262:C25217:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Assessment","conceptCode":"C25217","definition":"The final result of a determination of the value, significance, or extent of.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7952173B-DF16-DA26-E040-BB89AD432DA2","latestVersionIndicator":"Yes","beginDate":"2009-11-26","endDate":null,"createdBy":"MOROZOFA","dateCreated":"2009-11-26","modifiedBy":"ONEDATA","dateModified":"2009-11-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7952173B-DF27-DA26-E040-BB89AD432DA2","latestVersionIndicator":"Yes","beginDate":"2009-11-26","endDate":null,"createdBy":"MOROZOFA","dateCreated":"2009-11-26","modifiedBy":"KUMMEROA","dateModified":"2021-06-24","changeDescription":"2021-6-24 ak Released per Janet review.  2021-2-8 ak Entered NMDP Origin.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2695319","version":"1","longName":"NMDP: CDEs to review","context":"NHLBI","ClassificationSchemeItems":[{"publicId":"2964892","version":"1","longName":"2024r1: Sarcoma Pre-HSCT Data","context":"NHLBI"}]}],"AlternateNames":[{"name":"sar_base_diag_tmr_tst_kn","type":"NMDP_FN","context":"NHLBI"}],"ReferenceDocuments":[{"name":"Tumor mass was assessed by:","type":"Preferred Question Text","description":"Tumor mass was assessed by:","url":null,"context":"NHLBI"}],"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7952173B-DFF3-DA26-E040-BB89AD432DA2","latestVersionIndicator":"Yes","beginDate":"2009-11-26","endDate":null,"createdBy":"MOROZOFA","dateCreated":"2009-11-26","modifiedBy":"KUMMEROA","dateModified":"2021-06-24","changeDescription":"2021-6-24 ak Released per Janet review.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}